#Analgesic Infusion Pumps Market Demand

[lalsingh228-blog]

Analgesic Infusion Pumps Market to See Huge Growth by 2030

The Latest research coverage on Analgesic Infusion Pumps Market provides a detailed overview and accurate market size. The study is designed considering current and historical trends, market development and business strategies taken up by leaders and new industry players entering the market. Furthermore, study includes an in-depth analysis of global and regional markets along with country level market size breakdown to identify potential gaps and opportunities to better investigate market status, development activity, value and growth patterns. Access Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/5640-global-analgesic-infusion-pumps-market

Major & Emerging Players in Analgesic Infusion Pumps Market:- Becton Dickinson (United States), Baxter (United States), Medtronic (Ireland), ICU Medical (United States), B. Braun (Germany), Fresenius Kabi (Germany), Smiths Medical (United States), Terumo Corporation (Japan), Roche Diagnostics (Switzerland), Halyard Health (United States), Mindray Medical (China). The Analgesic Infusion Pumps Market Study by AMA Research gives an essential tool and source to Industry stakeholders to figure out the market and other fundamental technicalities, covering growth, opportunities, competitive scenarios, and key trends in the Analgesic Infusion Pumps market. Analgesic infusion pumps are usually plastic handheld devices which consist of a disposable syringe or a disposable, collapsible bag reservoir. It is a mechanism for propelling the infusate also called as a flowcontrol mechanism and is a means of displaying alarm conditions and/or user prompts. Analgesic infusion pumps are medical devices are used for controlling pain by delivering analgesic drugs to the patient through infusion pumps. Electronic models are powered by batteries, some comprises of software to help prevent medication errors. Most pumps are available with a case or pouch that can be attached to a belt.

The FDA announced three steps it would take to improve infusion pump safety. These steps were to (1) increase user awareness, (2) proactively facilitate device improvements, and (3) publish new guidance for industry. The titled segments and sub-section of the market are illuminated below: by Type (Volumetric, Ambulatory, Syringe), Application (Hospitals, Home Care, Ambulatory Care), Distribution Channel (Online, Offline) Market Trends: Technological advancements in the product

Government encouraging home healthcare therapies

Opportunities: Growing adoption of specialty infusion systems

Market Drivers: Increasing prevalence of chronic diseases

Growing home care market for infusion systems

Challenges: Growing incidence of medication errors Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/5640-global-analgesic-infusion-pumps-market Some Point of Table of Content: Chapter One: Report Overview Chapter Two: Global Market Growth Trends Chapter Three: Value Chain of Analgesic Infusion Pumps Market Chapter Four: Players Profiles Chapter Five: Global Analgesic Infusion Pumps Market Analysis by Regions Chapter Six: North America Analgesic Infusion Pumps Market Analysis by Countries Chapter Seven: Europe Analgesic Infusion Pumps Market Analysis by Countries Chapter Eight: Asia-Pacific Analgesic Infusion Pumps Market Analysis by Countries Chapter Nine: Middle East and Africa Analgesic Infusion Pumps Market Analysis by Countries Chapter Ten: South America Analgesic Infusion Pumps Market Analysis by Countries Chapter Eleven: Global Analgesic Infusion Pumps Market Segment by Types Chapter Twelve: Global Analgesic Infusion Pumps Market Segment by Applications What are the market factors that are explained in the Analgesic Infusion Pumps Market report?

– Key Strategic Developments: Strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors.

– Key Market Features: Including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin.– Analytical Tools: The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market. Buy This Exclusive Research Here: https://www.advancemarketanalytics.com/buy-now?format=1&report=5640 Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market. Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. Contact US : Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[credenceresearchdotblog]

The global demand for Pain Management Devices was valued at USD 8615.2 Million in 2023 and is expected to reach USD 5417.8 Million in 2032, growing at a CAGR of 8.90% between 2024 and 2032.Pain management devices are becoming increasingly significant in the healthcare industry, addressing a wide range of chronic and acute pain conditions. With advancements in technology and rising patient awareness, the pain management devices market is experiencing substantial growth. This article delves into the current landscape, key drivers, challenges, and future prospects of the pain management devices market.

Browse the full report at https://www.credenceresearch.com/report/pain-management-devices-market

Market Overview

The pain management devices market encompasses a variety of products designed to alleviate pain through non-invasive or minimally invasive means. These devices include electrical stimulators, radiofrequency ablation devices, analgesic infusion pumps, and neurostimulation devices. They are used to treat conditions such as arthritis, cancer, musculoskeletal disorders, and neuropathic pain.

Key Market Drivers

1. Rising Prevalence of Chronic Pain: Chronic pain affects millions globally, driven by factors such as aging populations, sedentary lifestyles, and increasing prevalence of conditions like diabetes and cancer. The growing need for effective pain management solutions is a primary driver of the market.

2. Technological Advancements: Innovations in pain management technologies, including the development of portable and wireless devices, have enhanced the efficacy and convenience of pain management. These advancements are attracting both healthcare providers and patients.

3. Increasing Preference for Non-Pharmacological Therapies: With concerns over opioid addiction and side effects of pain medications, there is a shift towards non-pharmacological pain management options. Devices offer a safer alternative with fewer side effects, contributing to their rising adoption.

4. Growing Geriatric Population: The aging global population is more prone to chronic pain conditions, increasing the demand for pain management devices. Elderly patients often prefer non-invasive treatments, further boosting market growth.

5. Favorable Reimbursement Policies: In many regions, reimbursement policies for pain management devices have become more favorable, making these treatments more accessible to a broader patient base.

Market Challenges

1. High Cost of Devices: The initial cost of pain management devices can be high, posing a barrier to widespread adoption, especially in low- and middle-income countries.

2. Lack of Awareness and Training: Despite the benefits, there is still a lack of awareness and proper training among healthcare providers regarding the use of advanced pain management devices, which can hinder market growth.

3. Regulatory Hurdles: The approval process for medical devices can be lengthy and complex, with stringent regulations that vary across regions. This can delay the introduction of new products to the market.

4. Side Effects and Complications: While generally safer than pharmacological treatments, some pain management devices can have side effects or complications, such as infections or device malfunctions, which can deter their use.

Regional Insights

The pain management devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America holds the largest market share, driven by high healthcare expenditure, advanced healthcare infrastructure, and a high prevalence of chronic pain conditions. Europe follows closely, with significant contributions from countries like Germany, France, and the UK.

The Asia-Pacific region is expected to witness the highest growth rate due to increasing healthcare awareness, improving healthcare infrastructure, and rising disposable incomes. Countries such as China and India are becoming significant markets for pain management devices, driven by their large patient populations and growing healthcare investments.

Future Prospects

The future of the pain management devices market looks promising, with continuous technological advancements and increasing investments in research and development. Emerging technologies such as wearable pain management devices and the integration of artificial intelligence for personalized pain treatment plans are expected to revolutionize the market.

Moreover, strategic collaborations and partnerships among key players, along with mergers and acquisitions, are likely to foster innovation and expand market reach. Companies are also focusing on expanding their product portfolios and geographical presence to capture a larger market share.

Key Players

B. Braun Melsungen AG

Baxte

Boston Scientific Corp.

Enovis

Medtronic

ICU Medical, Inc.

Abbott

Stryker

Nevro Corp.

Omron Healthcare, Inc.

Stimwave LLC

Segmentation

By Device Type

Neuromodulation Devices:

By Application Type

Neuropathic Pain

Cancer Pain

Musculoskeletal Pain

Migraine and Facial Pain

Trauma Pain

Postoperative Pain

Others

By End-User Type

Hospitals

Clinics

Ambulatory Surgical Centers (ASCs)

Rehabilitation Centers

Homecare Settings

By Technology Type

Implantable Pain Management Devices

Non-Implantable Pain Management Devices

By Mode of Purchase Type

Over-the-Counter (OTC) Pain Management Devices

Prescription-Based Pain Management Devices

By Product Innovation and Features Type

Wireless Pain Management Devices

Smart Pain Management Devices

Wearable Pain Management Devices

By Product Innovation and Features Type

Pediatric Pain Management Devices

Adult Pain Management Devices

Geriatric Pain Management Devices

By Patient Age Group Type

Nociceptive Pain

Neuropathic Pain

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[industryinsightsandanalysis]

Pain Management Devices Market Analysis and Forecast (2021-2027)

The global pain management devices market is anticipated to grow at a CAGR of approximately 8% from 2021 to 2027. This growth is driven by an increasing geriatric population, rising prevalence of chronic diseases, technological advancements in medical devices, and heightened awareness about pain management solutions.

Key Market Drivers:

1. Increasing Geriatric Population: The aging population is more prone to chronic diseases and pain, necessitating effective pain management solutions. For instance, the CDC reported that 5.8 million Americans were living with Alzheimer's disease in 2020, a number expected to nearly triple by 2060.

2. Prevalence of Chronic Diseases: Conditions such as arthritis and cancer, which are associated with significant pain, are on the rise. The CDC states that about 58.5 million U.S. adults have doctor-diagnosed arthritis.

3. Technological Advancements: Innovations in medical technology enhance the effectiveness and adoption of pain management devices. These advancements are pivotal in minimally invasive treatments, contributing to the growth of segments like RF ablation.

4. Rising Awareness: Increased awareness about the availability and benefits of pain management devices boosts market demand.

For a comprehensive analysis of the market drivers, visit: https://univdatos.com/report/pain-management-devices-market/

Market Segmentation:

1. By Product Type:

   - Electrical Stimulators: Devices that use electrical currents to relieve pain.

   - Radiofrequency (RF) Ablation: Expected to witness significant growth due to its minimally invasive nature and effectiveness in treating chronic pain.

   - Analgesic Infusion Pumps: Deliver analgesic medications directly to the bloodstream.

   - Neurostimulation: Use electrical impulses to interrupt pain signals to the brain.

   - Others: Include various emerging pain management technologies.

2. By Application:

   - Cancer: Accounts for a significant share due to the high incidence of cancer-related chronic pain. WHO reported nearly 10 million cancer-related deaths in 2020.

   - Neuropathic Pain: Chronic pain resulting from nerve damage.

   - Facial & Migraine Pain: Chronic headache and facial pain conditions.

   - Musculoskeletal Disorders: Conditions affecting muscles, bones, and joints.

   - Trauma: Pain resulting from injuries.

   - Others: Other chronic pain conditions.

3. By End-User:

   - Physiotherapy Centers: Specialize in physical rehabilitation and pain management.

   - Hospitals & Clinics: Hold a significant share due to their comprehensive treatment capabilities and high patient influx.

   - Others: Include home care settings and specialized pain clinics.

Regional Insights:

- North America: Dominates the market due to its advanced healthcare infrastructure and high healthcare spending. Canada's annual healthcare expenditure per person increased by about 9% from 2016 to 2019.

- Europe: Follows North America in market share, driven by high healthcare standards and investments.

- Asia-Pacific: Rapidly growing due to increasing healthcare access and expenditure.

- Rest of the World: Includes regions with developing healthcare systems but growing awareness and adoption of pain management devices.

Key Market Players:

Major players in the market include B Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., Nevro Corp., Enovis, OMRON Healthcare Inc., Medtronic plc, ICU Medical Inc., Abbott Laboratories, and Stryker Corporation. These companies are involved in mergers, acquisitions, and partnerships to enhance their product offerings and market reach.

For a sample report, visit https://univdatos.com/get-a-free-sample-form-php/?product_id=22791

Conclusion:

The pain management devices market is poised for substantial growth due to demographic shifts, rising chronic disease prevalence, and technological advancements. This growth will likely lead to more effective pain management solutions and improved patient outcomes.

Contact Us:

UnivDatos Market Insights

Email - contact@univdatos.com

Contact Number - +1 9782263411

Website -www.univdatos.com

[omkarpatel]

Pain Management Devices is Estimated to Witness High Growth Owing to Opportunity to Address Unmet Needs in Chronic Pain Management

Pain management devices are medical devices used for patients suffering from acute and chronic pain. These devices include neuromodulation devices, ablation devices, and analgesic infusion pumps. Neuromodulation devices such as Transcutaneous Electrical Nerve Stimulation (TENS) devices and Spinal Cord Stimulation (SCS) devices help manage both chronic and acute pain with minimal side effects. The global pain management devices market is estimated to be valued at US$ 6 billion in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The large unmet needs in chronic pain management presents a huge market opportunity for pain management devices. Chronic pain affects millions of people globally and significantly impacts their quality of life. However, currently available treatment options for chronic pain such as medications, have limited efficacy and are associated with dependence and addiction issues. This leaves a large patient population with inadequate pain relief. Pain management devices such as neurostimulation devices offer an alternative to medications for chronic pain management with minimal side effects. With increasing awareness about benefits of neurostimulation therapies and availability of advanced devices, the demand for pain management devices from chronic pain patients is expected to grow significantly over the forecast period thus driving the market growth. Porter's Analysis Threat of new entrants: The threat of new entrants is moderate as significant capital investment is required to manufacture medical devices. However, new players can enter through acquisition or by offering innovative products. Bargaining power of buyers: The bargaining power of buyers is high due to the presence of many established players providing alternative treatment options. Buyers can negotiate on price and demand continuous innovation. Bargaining power of suppliers: The bargaining power of suppliers is moderate as raw material suppliers have minimum differentiation. However, key component suppliers have some bargaining power. Threat of new substitutes: The threat of substitutes is moderate to high as alternative treatment options like medications, therapy, and surgeries are available. Development of new technologies poses a threat. Competitive rivalry: The competitive rivalry is high due to the presence of many global and regional players offering similar products. Players compete on innovation, quality, and performance. SWOT Analysis Strength: It offers non-invasive and minimally invasive treatment options with reduced pain and quick recovery.New products provide effective long-term pain relief and improved functional recovery. Weakness: High procedure and device costs can limit widespread adoption.Lack of awareness about new technologies in developing nations. Key Takeaways The global pain management devices market is expected to witness high growthduring the forecast period of 2023 to 2030. The market is estimated to grow at a CAGR of 6.5% during the forecast period. Growth drivers include rising geriatric population, increasing incidence of chronic conditions causing chronic pain, and growing preference for non-opioid therapies. Key players operating in the pain management devices market are Medtronic, Boston Scientific, Abbott, NeuroMetrix., and B Braun Melsungen. Medtronic maintains its leadership position in the market with its portfolio of both invasive and non-invasive neuromodulation systems to treat chronic pain. Boston Scientific focuses on less invasive procedures through minimally invasive implants and patient-specific therapy.

[healtcareindustry23]

Empowering Patients with Pain Relief: The Rising Market of Patient-Controlled Analgesic Pumps

The patient-controlled analgesic pumps (PCAs) market refers to the segment of the medical device industry that produces devices used for pain management. PCAs are a type of infusion pump that allows patients to self-administer pain medication at a safe and effective dosage. These devices are commonly used for post-surgical pain management, as well as for managing chronic pain conditions.

Key Components of PCAs:

PCAs typically consist of several key components, including:

Pump - The pump is responsible for delivering a controlled amount of medication to the patient.

Drug reservoir - The drug reservoir holds the medication that will be delivered by the pump.

Control module - The control module allows the patient to self-administer medication at a safe and effective dosage.

Catheter - The catheter is inserted into the patient's body to deliver the medication.

Get a Free Sample Reports:

Patient-controlled Analgesic Pumps Market

Market Growth:

The patient-controlled analgesic pumps market is expected to continue growing in the coming years, driven by several factors. One of the primary factors is the increasing demand for non-invasive and drug-free pain management solutions. PCAs provide patients with a way to manage their pain without the need for prescription drugs, which can be addictive and have harmful side effects.

Additionally, advancements in technology have made PCAs more user-friendly and effective, which has further fueled market growth. The COVID-19 pandemic has also contributed to market growth, as the need for effective pain management solutions has become more pressing due to increased stress and anxiety.

Conclusion:

The patient-controlled analgesic pumps market plays a critical role in providing patients with safe and effective pain management solutions. As the market continues to grow, we can expect to see new innovations and advancements that further enhance the usability and effectiveness of these devices. Despite the challenges facing the market, the increasing demand for non-invasive and drug-free pain management solutions will continue to drive demand for PCAs in healthcare facilities around the world.

[meditech-insights]

Pain Management Devices Market Forecast By Top Leading Players | Medtronic, Boston Scientific, Abbott, BD, Stryker

Pain is an unpleasant sensation and emotional experience usually caused by tissue damage. Pain can be either acute or chronic. According to the 2019 National Health Interview Survey, more than 7% United States adults had chronic pain syndrome, which limited their ability to perform out normal tasks at work.

The Global Pain Management Devices Market is expected to grow at a rate of 9% to reach ~$3.5 billion by 2026. Rising cases of chronic pain-inducing diseases (like diabetes, muscoskeletal disorders), increased geriatric population, favorable reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, rising R&D investment, increasing incidence of sports injuries and cancer, and growing demand for chronic pain management in home care treatment are some of the main factors driving the global pain management devices market.

Advent of Advanced Pain Management Technologies Drives the Pain Management Devices Market

At the moment, oral medications are the primary line of treatment for pain management since they are easily available and less expensive. The quality of treatment and care, however, has greatly improved in recent years as a result of the development of advanced technologies, FDA-approved non-prescription medical devices, devices used in combination with prescription medications, or other kinds of pain management therapy.

Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are numerous types of pain management devices available in the market.

Numerous advancements have recently been developed to improve the quality of life for people suffering from chronic pain, including:

In October 2021, SPR Therapeutics secured $37M VP funding to scale operations for Sprint pain relief device

In August 2020, Medtronic launched its FDA-approved neurostimulator, called the InterStim Micro Neurostimulator which helps patients to effective control bladder and bowel movement

Explore Premium Report on Pain Management Devices Market @ https://meditechinsights.com/pain-management-devices-market/

Key Challenges/ Constraints: Pain Management Devices Market

Patients with chronic pain who are no longer responding to drug therapy usually turn to pain management devices as a second line of treatment. Hypersensitivity reactions and post-operative infections caused due to the use of these devices are likely to hamper growth of the pain management devices market.

North America Leads in terms of Adoption of Pain Management Devices Market

With a >50% market share, North America dominates the market for pain management devices, followed by Europe and Asia Pacific. Some of the major factors influencing the market growth include the need for drug-free therapies, the availability of well-planned reimbursement and insurance coverage, and the presence of major players in this region.

Competitive Landscape Analysis of Pain Management Devices Market

The global pain management devices market is marked by presence of established key players such as Medtronic, Boston Scientific, Abbott, BD, Baxter International, Stryker, Smiths Medical, Nipro Corporation, Nevro Corp., Mindray Microtransponder, among others.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

[credenceresearchdotblog]

The balloon infuser market size stood at approximately $2,208.00 million USD, marking a pivotal point in its evolution. This figure, while substantial, merely hinted at the market’s potential for expansion. By 2032, the balloon infuser market had surged to an impressive $4,348.00 million USD, reflecting a compound annual growth rate (CAGR) of 6.66 percent. The balloon infusers market, a niche yet rapidly expanding segment of the medical devices industry, is witnessing significant growth driven by technological advancements, increasing prevalence of chronic diseases, and a growing emphasis on patient-centric healthcare solutions. Balloon infusers, also known as elastomeric infusion pumps, are compact, portable devices that deliver controlled amounts of medication, such as pain relief drugs, antibiotics, and chemotherapy agents, over a set period. This article delves into the current trends, market dynamics, key players, and future prospects of the balloon infusers market.

Browse the full report at https://www.credenceresearch.com/report/balloon-infusers-market

Market Overview

Balloon infusers are particularly popular in home healthcare settings due to their simplicity, reliability, and ease of use. These devices have become essential in outpatient care, enabling patients to receive continuous medication without the need for hospital stays. The growing preference for home-based treatments, spurred by the COVID-19 pandemic, has further fueled the demand for balloon infusers.

Key Market Drivers

1. Technological Advancements: Innovations in balloon infuser design and materials have significantly improved the accuracy and safety of these devices. Enhanced elastomeric materials offer better control over drug delivery rates, minimizing the risk of dosage errors and improving patient outcomes.

2. Rising Prevalence of Chronic Disease: The increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions necessitates long-term medication management. Balloon infusers provide a convenient solution for the continuous delivery of drugs, improving patient compliance and quality of life.

3. Shift Towards Home Healthcare: The healthcare industry is witnessing a paradigm shift towards home-based care, driven by the need to reduce hospital costs and the desire to enhance patient comfort. Balloon infusers support this trend by enabling patients to receive necessary treatments in the comfort of their homes.

4. Increasing Surgical Procedures: The rising number of surgical procedures globally has increased the demand for post-operative pain management solutions. Balloon infusers are widely used for administering local anesthetics and analgesics, ensuring effective pain control and faster recovery.

Market Challenges

Despite the promising growth prospects, the balloon infusers market faces several challenges:

1. Stringent Regulatory Requirements: The development and commercialization of medical devices are subject to rigorous regulatory scrutiny. Manufacturers must adhere to stringent quality standards and obtain necessary approvals, which can be time-consuming and costly.

2. High Costs: The initial cost of balloon infusers can be a barrier for some patients and healthcare providers. However, the long-term benefits and reduced hospital stay costs often offset this initial investment.

3. Limited Awareness: In certain regions, there is a lack of awareness among patients and healthcare professionals about the benefits and availability of balloon infusers. Educational initiatives and targeted marketing efforts are essential to overcome this hurdle.

Key Players and Competitive Landscape

The balloon infusers market is highly competitive, with several key players striving to enhance their market share through product innovation, strategic partnerships, and mergers and acquisitions. Some of the prominent companies in this market include:

- Baxter International Inc.: A global leader in healthcare products, Baxter offers a wide range of elastomeric infusion pumps known for their reliability and precision. - Fresenius Kabi AG: This German healthcare company provides innovative balloon infusers designed for various therapeutic applications, emphasizing patient safety and comfort. - B. Braun Melsungen AG: B. Braun's portfolio includes advanced elastomeric infusion devices that cater to diverse medical needs, backed by robust research and development capabilities. - Avanos Medical, Inc.: Specializing in pain management and chronic care, Avanos offers balloon infusers that are easy to use and ensure consistent drug delivery.

Future Prospects

The future of the balloon infusers market looks promising, with several trends shaping its trajectory:

1. Personalized Medicine: Advances in biotechnology and genomics are paving the way for personalized medicine, where treatments are tailored to individual patient needs. Balloon infusers can play a crucial role in this paradigm by providing customized drug delivery solutions.

2. Expansion in Emerging Markets: As healthcare infrastructure improves in emerging markets, the demand for advanced medical devices, including balloon infusers, is expected to rise. Companies are increasingly focusing on these regions to tap into the growing opportunities.

3. Integration with Digital Health: The integration of balloon infusers with digital health technologies, such as remote monitoring and telemedicine, can enhance patient care and compliance. These connected devices can provide real-time data to healthcare providers, enabling timely interventions and personalized treatment adjustments.

Key Players

Smiths Medical

Avanos Medical, Inc.

Ambu A/S

Halomedical Systems Ltd.

Pfm Medical Ag

Daiken Medical Co., Ltd.

Palex Medical SA

B. Braun Melsungen AG

Fresenius Kabi AG

Baxter International Inc.

Terumo Corporation

Nipro Corporation

Canack Technology Ltd.

PROMECON GmbH.

Segments

By Product:

Continuous-Rate Elastomeric Pumps

Variable-Rate Elastomeric Pumps

By Application:

Pain Management

Antibiotic Therapy

Antiviral Therapy

Chemotherapy

Others

By End User:

Hospitals

Ambulatory Surgical Centers

Home Care Settings

Speciality Clinics

Others

By Region:

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Rest of Asia-Pacific

Rest of the World

Middle East

Africa

Latin America

Browse the full report at https://www.credenceresearch.com/report/balloon-infusers-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

[nikhilghodse20051994]

Infusion Pumps Market Size, Share, Trends, Growth and Forecast Till 2028 | The Insight Partners

The Infusion Pumps Market was valued at US$ 11,378.8 million in 2017 and it is projected to reach US$ 18,045.6 million by 2025; it is expected to grow at a CAGR of 6.2% from 2018 to 2025.

The report highlights the trends prevalent in the global infusion pumps market and the factors driving the market along with those that act as restraints to its growth. The global infusion pumps market is witnessing a sheer rise in the current scenario and is expected to expand in the coming years. Growing geriatric population is an important factor expected to propel the demand of infusion pumps market.

Infusion pumps are widely used in geriatric population as it is an improved method to administer medication/ hormone/ nutrition and others. For instance, diabetes is a major cause of morbidity and mortality in ageing population that later largely attributable to various chronic complications. The number of ageing people with diabetes is increasing due to increased lifespan and the increased prevalence of diabetes in the geriatric population in the United States and worldwide. Infusion pump for diabetes provides more flexibility to the patient’s lifestyle while giving them greater control of the disease.

Get Sample PDF:

The plastic surgical procedures like liposuction, abdominoplasty, and mammoplasty, require short hospital stay, patients are discharged for ambulatory recovery on oral analgesic management. However, anesthetists have started using infusion pumps to achieve adequate outpatient analgesic control. These pumps continuously administer and maintain constant plasma concentrations. According to the American Society of Plastic Surgeons in 2017, there were around 17.5 million surgical and minimally invasive plastic procedures performed in the United States.

Global infusion pumps market, based on type was segmented as, ambulatory pumps, volumetric pumps, syringe pumps, and accessories. In 2017, volumetric pumps segment held the largest share by the market, by type. This is mainly attributed to the benefit such as, accurate administration of large volume of drugs to patients.

Buy Now: https://www.theinsightpartners.com/buy/TIPHE100001112/

The growth of the infusion pumps market is primarily attributed to increasing incidence of chronic diseases. Moreover, the increasing number of surgical procedures performed is expected to fuel the market growth. Infusion pumps are used during surgeries to send pain medicine through catheter to a specific part of your body. Infusion pumps can provide targeted and consistent medicine to decrease the pain. They are used when other methods are less effective or when the patient need long-term medicines or fluids.

The List of Companies

BD

B. Braun Melsungen AG

Terumo Corporation

F. Hoffmann-La Roche Ltd.

Medtronic

Baxter International, Inc.

Smith Medical

Moog, Inc.

ICU Medical, Inc.

Insulet Corporation

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

[medi-techinsights]

Global Pain Management Devices Market is set to grow at a decent rate of 9% to reach USD 3.5 billion by 2026

Pain is an unpleasant sensation and emotional experience usually caused by tissue damage. Pain can be either acute or chronic. In 2019, The National Health Interview Survey founded that more than 7% of adults in the US had chronic pain syndrome which hindered their normal activities in work place.

Advanced Pain Management Technologies

Currently, first line of treatment for pain management is oral medication due to their easy availability, and lower cost. However, in the recent years, due to development of advanced technologies, FDA approved non-prescription medical devices, devices used in combination with prescribed medications or other forms of pain management therapy, the quality of treatment and care has improved immensely.

There are various types of pain management devices available in the market such as spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices. Recently, many developments have been made to improve the quality of life of patients suffering from chronic pain such as:

In October 2021, SPR Therapeutics secured $37M VP funding to scale operations for Sprint pain relief device

In August 2020, Medtronic launched its FDA-approved neurostimulator, called the InterStim Micro Neurostimulator which helps patients to effective control bladder and bowel movement

Major Challenges: Global Pain Management Devices Market

Pain management devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy. Hypersensitivity reactions and post-operative infections caused due to the use of these devices are likely to hamper growth of the market.

North America Leads in terms of Adoption of Pain Management Devices Market

North America holds the largest market for pain management devices with >50% share, followed by Europe and Asia Pacific. Demand for drug free therapy, availability of well planned reimbursement and insurance coverage and presence of leading player in this region are the key factors driving the market growth.

Competitive Landscape Analysis: Pain Management Devices Market

The global Pain Management Devices Market is marked by the presence of established and leading players such as Medtronic, Boston Scientific, Abbott, BD, Baxter International, Stryker, Smiths Medical, Nipro Corporation, Nevro Corp., Mindray Microtransponder, among others.

Get Customized Report on Pain Management Devices Market @ https://meditechinsights.com/pain-management-devices-market/

[mrfrblogresearch02]

Pain Management Market Report to Cover Size, Share, Trend Analysis and Forecast 2027

Market Highlights:

Owing to the increasing technological advancements, the pain management market is expected to escalate. In the recent years, various new and existing marketers have come up with effective and new advancements in pain management. For instance, a new noninvasive neuromodulation device, Stimpod NMS460 has been introduced by the Xavant Technology to treat the chronic intractable pain. The device received FDA approval on August 01, 2017.

A number of factors such as improved reimbursement policies in developed countries, increasing prevalence of cancer pain, improving regulatory framework, growing research funding, unmet medical needs, rising competition among market players, and increasing government assistance are propelling the growth of the global Pain Management Market.

However, the high cost associated with technology, lack of skilled or trained physicians, and poor healthcare system in low and middle-income countries may hamper the growth of the market.

It is estimated that the pain management market is expected to register a CAGR 6.0% during the forecast period of 2018 to 2023.

Regional Analysis

The Americas dominates the pain management market owing to the increasing prevalence of chronic pain, well-developed technology, high healthcare expenditure, and the presence of leading players. According to a study published in the Drug and Alcohol Dependence Journal in 2017, more than 100 million adult Americans are living with chronic pain. Chronic low back pain and headaches are the most commonly diagnosed conditions. It is also stated that such conditions are more prevalent in women than men, i.e., 34.3% in women, and 26.7% in men in the United States.

Europe holds the second position in the pain management market. It is expected that the increasing contribution towards research and development and increasing competition among marketers are likely to drive the European pain management market.

Asia Pacific is the fastest growing pain management market owing to a huge patient pool, increasing demand for treatments, and increasing healthcare expenditure. As per the data suggested by the Australian Institute of Health and Welfare during 2015 to 2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014 to 2015.

The Middle East and Africa holds the lowest share of the global pain management market due to low development, lack of technical knowledge, and poor medical facilities.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5975

Segmentation

The global pain management market is segmented on the basis of type of pain management devices, type of pain management drugs, indication, mode of purchase, and end-user.

On the basis of type of pain management devices, the market is classified as neurostimulation devices, analgesic infusion pumps, and ablation devices. Neurostimulation devices are further segmented into Transcutaneous Electrical Nerve Stimulation (TENS) devices and Spinal Cord Stimulation (SCS) devices. Ablation devices are further segmented into RF ablation devices and cryoablation devices.

On the basis of type of pain management drugs, the market is classified as Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), anticonvulsants, anesthetics, opioids, antimigraine agents, antidepressants, and others. The opioids segment is further classified as oxycodones, hydrocodones, tramadol, morphine, codeine, fentanyl, meperidine, methadone, and others.

On the basis of indication, the market is classified as neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, fibromyalgia, chronic back pain, arthritic pain, migraine, post-operative pain, and others.

On the basis of the mode of purchase, the market is classified as over the counter and prescription-based.

On the basis of end-user, the market is classified as hospitals and clinics, pharmaceutical companies, medical device companies, research and academic institutes, and others.

Key Players

Some of the key players in the global pain management market are Abbott Laboratories, Abbvie, Allergan, Astellas Pharma, AstraZeneca plc, Bayer AG, Codman And Shurtleff, Inc, DJO Global LLC, Eli Lilly & Company, Endo Health Solutions, F. Hoffmann-La Roche Ltd, Forest Laboratories, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Mallinckrodt plc, Medtronic PLC, ST. Jude Medical, Inc., Boston Scientific Corporation, Pfizer Inc., Halyard Health, Inc., Smiths Medical, B. Braun Melsungen AG, Neurotech Na, Inc., Becton, Dickinson and Company, Nevro Corp., Merck & Co. Inc., Novartis AG, Purdue Pharma LP, Sanofi, Stryker Corporation, Teva Pharmaceuticals, and others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/pain-management-market-5975

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[adityarana1687-blog]

Pain Management Devices Market Projected To Show Considerable Growth By 2027

The global pain management devices market size is expected to reach USD 10.86 billion by 2027 registering a CAGR of 9.0%, according to a new report by Grand View Research, Inc. Increasing cases of chronic pain and technological advancement are driving the market growth. The rising prevalence of chronic diseases coupled with the increasing geriatric population across the globe is the major factor augmenting the growth of this market. Preference for pain management devices over oral drugs and surgical interventions is also likely to be a high impact rendering driver for the market over the forecast period. The global market is expected to witness strong growth as a result of various technological advancements in this field.

The recent electrostimulation devices that are launching in the marketplace have advancements in the form of Microelectromechanical Systems (MEMS), Artificial Intelligence (AI), and machine learning applications. Most of the elective surgeries were postponed or canceled during the Covid-19 pandemic to decrease the exposure of the patients as well as the healthcare providers, which is expected to increase the demand for pain management devices. In August 2020, the U.S. FDA issued an Emergency Use Authorization (EUA) for the non-invasive vagus nerve stimulator to assist Covid-19 patients at home with asthma-related dyspnea.

Request a free sample copy or view report summary: Pain Management Devices Market Report

Pain Management Devices Market Report Highlights

The neurostimulation segment dominated the market with a share of over 57% in 2019 owing to the increased prevalence of neurological disorders

The radiofrequency ablation segment is expected to show lucrative growth over the forecast period owing to the growing prevalence of chronic and cardiovascular diseases and preference for minimally invasive surgeries

Neuropathic pain dominated the application segment with a share of more than 30% in 2019 and will expand further at a steady CAGR from 2020 to 2027 due to rising cases of neuropathic pain and new product launches by the industry players

The cancer application segment is expected to register the fastest growth over the forecast period owing to the increasing usage of pain management devices

Pain Management Devices Market Segmentation

Grand View Research has segmented the global pain management devices market on the basis of product, application, and region:

Pain Management Devices Product Outlook (Revenue, USD Million, 2016 - 2027)

Electrical Stimulators

Radiofrequency Ablation

Analgesic Infusion Pumps

Neurostimulation

TENS

Others

Intrathecal Infusion Pumps

External Infusion Pumps

Spinal Cord Stimulators

Deep Brain Stimulators

Sacral Neurostimulators

Others

Pain Management Devices Application Outlook (Revenue, USD Million, 2016 - 2027)

Cancer

Neuropathic Pain

Facial & Migraine

Musculoskeletal Disorder

Trauma

Others

Pain Management Devices Regional Outlook (Revenue, USD Million, 2016 - 2027)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

U.K.

Germany

France

Italy

Spain

The Netherlands

Japan

China

India

Australia

Mexico

Brazil

Argentina

South Africa

Saudi Arabia

List of Key Players of Pain Management Devices Market

Smiths Medical

B. Braun Melsungen AG

Baxter

Boston Scientific Corp.

Colfax Corp.

Medtronic Plc

Nevro Corp.

Abbott

Stryker

Omron Healthcare, Inc.

Stimwave LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

[chitrakullkarni]

Home Infusion Therapy Market Global Demand, Application Outlook and Research Report

The global Home Infusion Therapy Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview:

The global Home Infusion Therapy Market is anticipated to grow at a significant CAGR during the forecast period. Home infusion therapy is an integral part of professional practice in developed countries. Though the patients’ scenarios are different under various circumstances, a considerable amount of risk is always involved. The nature of home infusion therapy is not only limited to patient care and device, but also it actively involves accumulation of consumables and enactment of quality improvement and research activities.

Key Players:

Braun Melsungen AG

Baxter

Caesarea Medical Electronics

CareFusion Corporation

Fresenius Kabi

ICU Medical Inc.

JMS Co. Ltd.

Smiths Medical

Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/home-infusion-therapy-market/request-sample

Growth Drivers:

Driving factors for home infusion therapy market include rise in geriatric population and availability of medical attention under a strong infrastructure. Apart, homecare therapies/home infusion therapies are gaining a significant traction in the low income regions since medical needs are unavailable during emergencies. Medical practices inclined towards patient betterment are expected to gain a huge traction in the forecast period. However, expensive nature of home infusion therapy might challenge the market demand. Product segment for home infusion therapy market includes infusion pump sets, IV cannulas and needleless connectors. Application segment includes endocrinology, parenteral nutrition, and hydration therapy.

Product Outlook:

Infusion pumpsAmbulatory infusion pumps Insulin pumps Syringe pumps Elastomeric pumps Patient Controlled Analgesics (PCA)

Intravenous Sets

IV Cannulas

Needleless Connectors

Application Outlook:

Anti-Infectives

EndocrinologyDiabetes

Hydration TherapyAthletes

Chemotherapy

Enteral Nutrition

Parenteral Nutrition

Specialty Pharmaceuticals

Regional Outlook:

Geographical segmentation for home infusion therapy market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America accounts for a significant market share in the forecast period due to rise in government support and advances in medical technology. Medical benefits offered by government in these regions are likely to trigger the market growth.

Asia-Pacific regions are likely to grow at a significant share in the global market due to presence of medical infrastructure and rise in patient awareness. The homecare therapies are gaining traction due to emphasis on patient betterment and proper medical attention for geriatric patients. The key players in the home infusion therapy industry include Baxter, B.Braun Melsungen AG, Caesarea Medical Electronics, ICU Medical Inc, Care Fusion Corporation, Fresenius Kabi AG, Terumo Corporation, Smiths Medicala and JMS Co Ltd.

Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/

[daisyri-me]

Home Infusion Therapy Market : Current Trends and Market Challenges by 2024

The global Home Infusion Therapy Market is anticipated to grow at a significant CAGR during the forecast period. Home infusion therapy is an integral part of professional practice in developed countries. Though the patients’ scenarios are different under various circumstances, a considerable amount of risk is always involved. The nature of home infusion therapy is not only limited to patient care and device, but also it actively involves accumulation of consumables and enactment of quality improvement and research activities.

Free Exclusive Sample of this Report @ https://www.millioninsights.com/industry-reports/home-infusion-therapy-market/request-sample

Driving factors for home infusion therapy market include rise in geriatric population and availability of medical attention under a strong infrastructure. Apart, homecare therapies/home infusion therapies are gaining a significant traction in the low income regions since medical needs are unavailable during emergencies. Medical practices inclined towards patient betterment are expected to gain a huge traction in the forecast period. However, expensive nature of home infusion therapy might challenge the market demand. Product segment for home infusion therapy market includes infusion pump sets, IV cannulas and needleless connectors. Application segment includes endocrinology, parenteral nutrition, and hydration therapy.

Geographical segmentation for home infusion therapy market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America accounts for a significant market share in the forecast period due to rise in government support and advances in medical technology. Medical benefits offered by government in these regions are likely to trigger the market growth.

Asia-Pacific regions are likely to grow at a significant share in the global market due to presence of medical infrastructure and rise in patient awareness. The homecare therapies are gaining traction due to emphasis on patient betterment and proper medical attention for geriatric patients. The key players in the home infusion therapy industry include Baxter, B.Braun Melsungen AG, Caesarea Medical Electronics, ICU Medical Inc, Care Fusion Corporation, Fresenius Kabi AG, Terumo Corporation, Smiths Medicala and JMS Co Ltd.

Browse Full Report With TOC @ https://www.millioninsights.com/industry-reports/home-infusion-therapy-market

Market Segment:

Product Outlook (Market revenue in USD Million, 2013 - 2024)     • Infusion pumps         • Ambulatory infusion pumps         • Insulin pumps         • Syringe pumps         • Elastomeric pumps         • Patient Controlled Analgesics (PCA)     • Intravenous Sets     • IV Cannulas     • Needleless Connectors

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:ryan@millioninsights.com

[meditech-insights]

Pain Management Devices Market – Insights on Upcoming Trends 2026

Pain is an unpleasant sensation and emotional experience usually caused by tissue damage. Pain can be either acute or chronic. In 2019, The National Health Interview Survey founded that more than 7% of adults in the US had chronic pain syndrome which hindered their normal activities in work place.

The Global Pain Management Devices Market is anticipated to grow at a rate of 9% to reach ~$3.5 billion by 2026. Growing cases of chronic pain-inducing diseases (like diabetes, muscoskeletal disorders), increase in geriatric population, favorable reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, rising R&D investment, growing incidence of sports injuries and cancer, and rising demand for chronic pain management in home care treatment are some of the key factors driving the global pain management devices market.

Arrival of Advanced Pain Management Technologies Drives the Market Presently, first line of treatment for pain management is oral medication due to their easy availability, and lower cost. However, in the recent years, due to development of advanced technologies, FDA approved non-prescription medical devices, devices used in combination with prescribed medications or other forms of pain management therapy, the quality of treatment and care has improved immensely.

There are various types of pain management devices available in the market such as spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices. Recently, many developments have been made to improve the quality of life of patients suffering from chronic pain such as:

·In October 2021, SPR Therapeutics secured $37M VP funding to scale operations for Sprint pain relief device

·In August 2020, Medtronic launched its FDA-approved neurostimulator, called the InterStim Micro Neurostimulator which helps patients to effective control bladder and bowel movement

Get Customized Report on Pain Management Devices Market @ https://meditechinsights.com/pain-management-devices-market/

Key Challenges/ Constraints of Pain Management Devices

Pain management devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy. Hypersensitivity reactions and post-operative infections caused due to the use of these devices are likely to hamper growth of the market.

North America Leads in terms of Adoption

North America holds the largest market for pain management devices with >50% share, followed by Europe and Asia Pacific. Demand for drug free therapy, availability of well-planned reimbursement and insurance coverage and presence of leading player in this region are some of the key factors driving the market growth.

Competitive Landscape: Pain Management Devices Market The Pain Management Devices market is marked by presence of established key players such as Medtronic, Boston Scientific, Abbott, BD, Baxter International, Stryker, Smiths Medical, Nipro Corporation, Nevro Corp., Mindray Microtransponder, among others.

For More Details, Please Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact Us: Ruta Halde Associate, Medi-Tech Insights +32 498 86 80 79 info@meditechinsights.com

[fostermarketarch]

Pain Management Devices Market| Key Performing Regions| Drivers And Challenges

Pain management devices are designed to ease chronic pain from conditions, like fibromyalgia, diabetic neuropathy, sciatica, and osteoarthritis. Some of these devices deploy infrared light energy to relieve pain, by tapping into the body’s natural pain response and blocking the pain signals. All the pain management devices are designed to help relieve muscular and joint pains, improve blood circulation, cope with migraines and arthritis, or deal with the aches and pains of a long day at work, or at the gym. Growing demand for long-term pain management among the geriatric population, large patient population base, and adverse effects of pain medications are some of the key factors that have increased the demand for the pain management devices market.

These drug-free devices often have little to no side effects and this guide will allow you to browse different treatment options at a glance. Each product has benefits – for starters, you don’t need to be at the doctor’s office to use these devices and you get to be in charge of when and how often you put them to use – as well as drawbacks (like cost), so talk to your doctor if you think one might be a good fit for you.

Get Free PDF Brochure of this Report @https://www.fostermarketresearch.com/product/industry/7/91/Pdf%20Brochure/

Competitve Landscape:

Key players in the global pain management devices market include Medtronic PLC, Becton, Dickinson and Company, ST. Jude Medical, Inc., Boston Scientific Corporation, Hospira, Inc. (A Subsidiary of Pfizer Inc.), Halyard Health, Inc., Smiths Medical, B. Braun Melsungen AG, Neurotech Na, Inc., and Nevro Corp.

The players have adopted product development strategies to strengthen their position in the market. For instance, in January 2019, Boston Scientific Corporation launched Spectra WaveWriter, a new spinal cord stimulation device in Europe market. The newly launched devices by the company are the only devices available in the current market, which are paresthesia and sub-perception therapy based. In addition, substantial FDA approvals for the pain management devices also boost the market growth. For instance, in August 2018, the U.S.-based neurostimulation company, Nevro received FDA approval for its new Senza II, a spinal cord stimulation system.

The system is capable of providing HF10 therapy, which is relatively superior over traditional spinal cord stimulation system. Additionally, in July 2016, SPR Therapeutics received FDA approval for its newly developed pain management device, SPRINT. The newly developed device acts as a wearable stimulator and holds the capability to relieve pain with the help of electric stimulation.

Market Taxonomy:

By Device Type

Neurostimulation Devices Transcutaneous Electrical Nerve Stimulation (TENS) Devices Spinal Cord Stimulation (SCS) Devices)

Radiofrequency Ablation

NeurostimulationSpinal Cord Stimulators Deep Brain Stimulators Sacral Neurostimulators

Analgesic Infusion PumpsIntrathecal Infusion Pumps External Infusion Pumps

Ablation Devices

By Application

Neuropathic Pain

Cancer Pain

Facial Pain and Migraine

Musculoskeletal Pain

Other Applications

For More Information of this Report @https://www.fostermarketresearch.com/product/industry/7/91/

Market Dynamics:

Growing demand for long-term pain management among the geriatric population boosts the market growth. As the benefits of pain management devices have been unfolded in recent years, there has been an increase in adoption for these devices across the world. There has been a gradual increase in clinical approvals for these devices in recent years, resulting from the increasing demand for pain management devices. Additionally, the rising FDA approvals for neuromodulation devices have also driven the market growth.

According to the International Neuromodulation Society, the total number of approvals for neuromodulation devices from the Food and Drug Administration increased by approximately 35% in the past decade. The rising incidence of chronic ailments, such as diabetes, cancer, cardiovascular disorders, and others, may result in intense pain in patients. This is a key factor fueling the demand for pain management devices. Furthermore, the market is likely to benefit from the increasing willingness among patients to spend on advanced treatments. The increase in demand for pain management devices is mainly because of the pain caused by the tumor while it compresses a nerve and many more factors depending upon what stage of cancer the patient is undergoing.

Key Region Covered in Pain Management Devices Market are

North America (USA, Canada, and Mexico)

Europe (Germany, France, the United Kingdom, Netherlands, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, rest of countries, etc.)

The Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Nigeria, and South Africa)

Benefits You Gain With Our Research Methodology:

Develop your Business strategies to refine the profits in near team.

Grow your Business profit ratio through our analytics report.

Acquire the valuable insights on different products, services and technology along with their obsolescence nature in the foreseen period.

Gain and upper hand on competition by having competitive financial, growth and economic data.

Identity future threats by our accurate forecasting strategies.

Obtain Go-To market strategy to increase your chances in the existing market.

Buy Now This Business Strategic Report to Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/7/91/

About Foster Market Research:

Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data.

Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience.

Contact Us:

1701 Royal Lane, #1306, Dallas Tx-75229 Phone: +1 469 4981929 Email: support@fostermarketresearch.com